We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Bioadhesive Sponge Stops Uncontrolled Internal Bleeding During Surgery

By HospiMedica International staff writers
Posted on 20 Oct 2025

Uncontrolled internal bleeding remains one of the most critical and life-threatening challenges in surgery and trauma care, particularly when it involves vital organs like the liver or spleen. More...

Existing hemostatic agents often fail to adhere securely to wet tissue or do not degrade safely, sometimes leading to inflammation and the need for additional surgery. Now, a new bioabsorbable hemostatic sponge offers a fast, safe, and biodegradable way to control severe internal bleeding and support wound recovery.

Developed by researchers at Pohang University of Science and Technology (POSTECH, Pohang, South Korea), the bioadhesive sponge combines mussel adhesive protein with decellularized extracellular matrix (dECM). Inspired by the natural stickiness of mussels and the structural properties of biological tissues, the design enables strong tissue adhesion and promotes healing. The composite sponge rapidly absorbs blood and firmly attaches to injured tissues while activating the body’s natural coagulation pathways for accelerated clot formation and stabilization.

In preclinical tests using an anticoagulated liver injury model, the sponge adhered tightly to damaged tissue and achieved highly effective hemostasis. Bleeding time was significantly shortened, and total blood loss markedly decreased compared to conventional materials. The results, published in Advanced Healthcare Materials, also showed that the sponge caused less inflammation and tissue damage while enhancing wound stabilization during the early healing phase.

In addition to its strong adhesive and biodegradable properties, the sponge addresses key limitations of current hemostatic technologies by eliminating the risk of foreign-body retention and secondary complications. The material’s bioabsorbable nature reduces the need for surgical removal, while its bioactive components support faster tissue recovery. The research demonstrates a new way to safely and effectively manage internal organ bleeding, and researchers plan to explore clinical applications in trauma surgery.

“This composite sponge can stop bleeding quickly and safely even in severe internal injuries that were previously difficult to control,” said POSTECH Professor Hyung Joon Cha, who led the study. “By reducing the need for additional surgeries and supporting faster recovery, it has the potential to greatly improve patient care.”

Related Links:
POSTECH


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.